The Sarcoma Foundation of America has developed a program to provide grants to investigators interested in translational science Sarcoma research. Funding of up to $50,000, allowing up to 10 percent indirect costs, is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human Sarcomas.
In accordance with the mission of the Foundation, research involving the development of novel agents against Sarcoma, or research that could potentially lead to the development of novel agents against Sarcoma, is eligible for this funding. The SFA will only accept applications that focus on the following areas of research:
• Omic characterization of sarcomas and definition of novel targets
• Omic patterns of sensitivity and resistance to existing agents
• Systemic therapy combinations
In compliance with IRS instructions, grants cannot fund clinical trials, but all other areas of research can be considered for funding.
Interested parties may begin submitting grant applications on October 1, 2013. Grants will be reviewed by the SFA Medical Advisory Board immediately following the application deadline of 5:00 pm EST on January 31, 2014. Applicants will be notified in early April as to the award decision for their proposal. The funds awarded will be then available for research by June 1, 2014.
Researchers must submit proposals electronically at proposalCENTRAL. First-time users will be required to register and complete a professional profile in order to apply for an SFA research grant. The SFA will no longer accept applications via e-mail.
Information on sarcoma subtypes, treatments, clinical trials, and other important resources for sarcoma patients and families.
Information on the Sarcoma Patient Registry. If you are diagnosed with sarcoma, please consider joining the Registry.
Information on applying for a sarcoma research grant, current research funded by the SFA, and past research grants.